Amy Bryson

Vascular Flow Technologies Ltd

Vascular Flow Technologies is a dynamic, growing medical devices company - we operate in Europe and the US and our Head Office is in Scotland, UK. We are focused on the research, development and commercialisation of vascular devices based on a new understanding of blood flow dynamics – Spiral Laminar Flow™ How we started Vascular Flow's novel technology was developed from Ninewells Hospital (teaching hospital in Dundee, Scotland) by three leading physicians, Professor Peter Stonebridge, following his return from Harvard , Dr John Dick and Professor Graeme Houston. We launched our first product in late 2008 and a second product in June 2010. We have ambitious plans to grow our business globally and for surgeons and patients all over the world to benefit from Spiral Flow™ products. Innovative technology Our innovative technology is currently applied to two synthetic grafts: our Spiral Flow™ peripheral bypass graft and our Spiral Flow™ arteriovenous access graft for haemodialysis. Vascular Flow grafts are the ONLY grafts proven to recreate Spiral Laminar Flow™, the body's natural blood flow pattern, improving graft patency and helping to prevent disease progression resulting in better outcomes for the surgeon, care-giver and patient. Technology Development The company is currently developing new products using the SLF™ technology platform and has accumulated considerable experience and understanding of pre-clinical development and testing processes during the journey. Having taken products from concept to regulatory approval, VFT is well placed to offer this service to others embarking on a similar path. VFT has evolved into an ISO 13485 Medical Device Development company with unique insight and capabilities in pre-clinical development and testing. We now work in partnership with a number of medical device companies, Universities and SMEs offering a tailored service to assist their development process.